Over age 35 years, a higher ER+ proportion among US white than black women with breast cancer is driven by the latter group's slightly higher absolute incidence rate of triple negative disease, in combination with their much lower incidence rate of better prognosis ER+/PR+ HER2− tumors [102]. This evidence concerns the gene ESR1 and breast carcinoma.